Table 4.
Treatment satisfaction and perception of hyper/hypoglycemia (as measured by DTSQ) and fear of hypoglycemia (as measured by HFS): comparison between FGM1 (weeks 1–4) and FGM2 (weeks 5–12)
| Outcome measure | FGM1 (weeks 1–4) | FGM2 (weeks 5–12) | FGM2 (weeks 5–12) versus FGM1 (weeks 1–4) | |
|---|---|---|---|---|
| Mean (SD) | Mean (SD) | MD (95% CI) | p value | |
| DTSQ: global satisfaction | 26.7 (5.4) | 29.6 (5.9) | 2.2 (0.6 to 3.7) | 0.007 |
| Median (IQR) | Median (IQR) | Median of the differences (95% CI) | p value | |
| DTSQ: question concerning perception of hyperglycemia | 4 (3–5) | 3 (2–3) | − 1 (− 2 to 0) | 0.37 |
| DTSQ: question concerning perception of hypoglycemia | 3 (2–4) | 3 (2–3) | 0 (− 1 to 0) | 0.99 |
| Mean (SD) | Mean (SD) | MD (95% CI) | p value | |
| HFS: total | 43.8 (25.9) | 28.6 (19.4) | − 15.2 (− 25.3 to − 5.1) | 0.004 |
| HFS: behaviors | 20.8 (10.2) | 14.9 (9.5) | − 5.9 (− 10.5 to − 1.4) | 0.01 |
| HFS: worries | 22.9 (16.6 | 13.7 (11.5) | − 9.3 (− 15.3 to − 3.3) | 0.003 |
CI confidence interval, DTSQ Diabetes Treatment Satisfaction Questionnaire, HFS Hypoglycemia Fear Survey, MD mean difference, SD standard deviation